Transcriptome-based NGS outperforms traditional viral testing with superior sensitivity, detecting viruses including novel ...
In vitro skin irritation testing has emerged as a critical component in the safety evaluation of chemicals and medical devices, aiming to replace traditional animal-based assays. Central to this ...
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and ...
Advances in biofabrication and 3D in vitro model systems are transforming biomedical research, drug development, and toxicity testing. However, despite ...
NEW YORK CITY, NY, UNITED STATES, February 10, 2025 /EINPresswire.com/ -- Creative Bioarray, a pioneer in providing innovative solutions for biological research and ...
Etelka is a post-doctoral research fellow exploring aerosol science with biology and engineering.View full profile Etelka is a post-doctoral research fellow exploring aerosol science with biology and ...
The FDA cleared its first in vitro test to help determine whether people showing signs of cognitive decline also carry one of the hidden hallmarks of Alzheimer’s disease. The diagnostic detects ...
The World Health Organization (WHO) has listed the first mpox in vitro diagnostic (IVD) under its Emergency Use Listing (EUL) procedure, an important step in improving global access to mpox testing.
IVD, or in-vitro diagnostics are tests done on sample like blood or tissue that were taken from the human body. They can be used to detect diseases or other conditions and to monitor a person's ...
A federal district court has struck a blow for medical innovation and patient empowerment by overruling the Food and Drug Administration's (FDA) misbegotten effort to regulate laboratory-developed ...
FOR BIOTECH, DEB, IT REALLY IS. IN THE PAST LEGISLATIVE SESSION, MARYLAND’S GENERAL ASSEMBLY PASSED A BILL PROVIDING GRANTS TO MARYLAND SCIENTISTS WHO DEVELOP NON ANIMAL BASED RESEARCH METHODS. IT WAS ...